Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simvastatin add-on to escitalopram in adults with obesity and major depression
2018-002947-27Phase 2Completed
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in major depressive disorder (MDD) comparing Simvastatin add-on arm with Placebo add-on arm (2 arms). Primary endpoint: Change from baseline to week 12 in Montgomery-Asberg Depression Rating Scale. Started Mar 2019; status: completed.
02
Drugs
Simvacard
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on 2018-002947-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-002947-27.